Photo: mcw.edu
Feb 1, 2026, 11:32
Qizhen Shi։ A Padua Moment for Factor VIII Gene Therapy
Qizhen Shi, Professor at Medical College of Wisconsin, Program Co-Leader of Thrombosis and Hemostasis at Versiti Blood Research Institute, shared on LinkedIn:
”Honored to share that my Blood Commentary, ‘A Padua moment for factor VIII gene therapy,’ has now been published.
The Commentary discusses a newly engineered FVIII variant with improved secretion and cofactor activity, offering a Padua-like advance for hemophilia A gene therapy by enabling efficacy at substantially lower vector doses.
Congratulations to the authors of the original study, and thank you to the Blood editorial team for the invitation.”
Stay updated with Hemostasis Today.
-
Aug 15, 2026, 19:24Megan Adediran: An Unwavering Fight for People Living With Haemophilia
-
Aug 15, 2026, 19:23Intravenous Anticoagulation Linked to Worse Early Outcomes After Noncardioembolic Stroke – International Journal of Stroke
-
Aug 15, 2026, 18:03Alejandro González Veliz: Pulmonary Embolism Is Not Always an Anticoagulation-Only Problem
-
Aug 15, 2026, 17:57Ayesha Zia: A New Foundation for Pediatric Pulmonary Embolism Research and Care
-
Aug 15, 2026, 17:50Muhammad Shaheer Bin Faheem: 25 Years of Thromboembolism and Hypertension Mortality
-
Aug 15, 2026, 17:21Bilal Salman։ NETosis as a Therapeutic Target in Inflammation and Thrombosis
-
Aug 15, 2026, 16:58Andrew Jackson: Oral Anticoagulants for the Prophylaxis of Catheter-Related Thrombosis
-
Aug 15, 2026, 16:52Understanding Blood Clots During Pregnancy and After Birth – Thrombosis UK
-
Aug 15, 2026, 16:39Liri Seraj: How Summer Dehydration Affects Blood and Thrombosis Risk